Last reviewed · How we verify
PRS-060
At a glance
| Generic name | PRS-060 |
|---|---|
| Sponsor | Pieris Australia Pty Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma (PHASE1)
- Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects (PHASE1)
- Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PRS-060 CI brief — competitive landscape report
- PRS-060 updates RSS · CI watch RSS
- Pieris Australia Pty Ltd portfolio CI